First Tracks Biotherapeutics, Inc. has filed an 8-K form with the SEC, indicating a material event. Investors will be scrutinizing the filing for details on corporate changes or significant developments.
First Tracks Biotherapeutics Files Material Event Report with SEC
SEC filing8-Kbiotechnologycorporate governance
